SR

Sarojni Rambal

Active Director Director DIN 02020944
DIN 02020944 First appointment Jul 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Jul 2008
Shareholding value •••• Premium profile

About Sarojni Rambal

Data last updated:

Sarojni Rambal is a Director at Perdaman Pharmaceuticals Private Limited (since 2017) and Director at Shirdi Bio Fuels Private Limited (since 2017). The companies operate in Pharma, Agriculture and Media and Publishing. The 2 current companies with reported revenue have a combined latest revenue of ₹29.39 Cr; the largest is Perdaman Pharmaceuticals Private Limited at ₹28.76 Cr (FY 2025). Earlier, Sarojni Rambal was a Director at Sunrise International Labs Limited (2017–2025) and Director at Perdaman Corporate Services Private Limited (2008–2010).

DIN 02020944
Primary Designation Director
Industry Pharma
First Appointment 07 Jul 2008
Oldest Company Age 18 yrs
Largest company Perdaman Pharmaceuticals Private Limited · ₹28.76 Cr (FY 2025)
Combined revenue ₹29.39 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jan 20172008₹28.76 Cr (FY 2025)Active
Shirdi Bio Fuels Private Limited U01403DL2007PTC170200
Director24 Jan 20172007₹62.6 Lakh (FY 2020)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunrise International Labs Limited U24239TG1993PLC015367
Director24 Jan 20171993₹21.39 Cr (FY 2024)Active
Director07 Jul 20082008₹68.8 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shirdi Bio Fuels Private Limited
Perdaman Pharmaceuticals Private Limited
Sunrise International Labs Limited
Perdaman Corporate Services Private Limited
Premium access

Shareholding and investment profile for Sarojni Rambal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarojni Rambal

Sarojni Rambal currently holds 2 directorships: Perdaman Pharmaceuticals Private Limited (Director, since 24 Jan 2017, revenue ₹28.76 Cr (FY 2025)); Shirdi Bio Fuels Private Limited (Director, since 24 Jan 2017, revenue ₹62.6 Lakh (FY 2020)).

Sarojni Rambal was first appointed on 07 Jul 2008 as Director at Perdaman Corporate Services Private Limited. The most recent appointment on record is 24 Jan 2017 at Sunrise International Labs Limited.

The 2 current companies of Sarojni Rambal that report revenue have a combined latest revenue of ₹29.39 Cr: Perdaman Pharmaceuticals Private Limited ₹28.76 Cr (FY 2025); Shirdi Bio Fuels Private Limited ₹62.6 Lakh (FY 2020).

Sarojni Rambal held 2 earlier board appointments: Sunrise International Labs Limited (Director, 24 Jan 2017 to 02 Apr 2025); Perdaman Corporate Services Private Limited (Director, 07 Jul 2008 to 15 Oct 2010).

The current boards of Sarojni Rambal's companies include Dhruv Garg (Perdaman Pharmaceuticals Private Limited), Manoj Kumar Rambal (Perdaman Pharmaceuticals Private Limited), Samir Madhukar Garud (Perdaman Pharmaceuticals Private Limited), Shubham Kumar Namdev (Perdaman Pharmaceuticals Private Limited), Usha Rambal (Perdaman Pharmaceuticals Private Limited), Vikas Rambal (Perdaman Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available